ArticleJournal of inflammation research2024

Prediction of the Short-Term Effectiveness of Ustekinumab in Patients with Moderate to Severe Crohn's Disease.

Tao Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.